BfArM GCP Dialog
07 May 2019
Bonn, Germany
BfArM, one of the two German regulatory authorities, invites to a dialog about GCP requirements subsequent to the June 2017 effective date of ICH E6 (R2) that led to a number of new specifications and amendments of that guideline.
The increased use of modern information technology and the extensive outsourcing of sponsor tasks to CROs and other service providers in clinical trials were the primary triggers for the GCP guideline amendment. Thus, the main topics of the BfArM event include structural and record management demands for clinical trials as well as GCP requirements for investigators and sponsors to ensure accurate reporting, interpretation and verification of the obtained clinical trial information.
Dr. Hendrik Stempel, SanaClis’ Clinical Trial Coordinator Germany, will attend the meeting, participate in the dialog and ensure that SanaClis is applying best practices in clinical trial conduct as demanded by ICH E6 (R2) and expected by German regulators.
For more information about the event visit https://www.bfarm.de/DE/Service/Veranstaltungen/Dialogveranstaltungen/2019/190507-GCP.html;jsessionid=782B33FFAD9FDA6A3EC2161CA7011615.2_cid319
We are hiring

placeGLOBAL
Business Development
placeCENTRAL & EASTERN EUROPE
Clinical Research Associate for Czech Republic, Prague
Clinical Research Associate
Project Manager
Clinical Data Manager
SAS programmer and Senior Statistician position
placeSLOVAKIA & UKRAINE
Logistic Coordinator
Warehouse Manager & Assistant
This website uses cookies. By using and further navigating this website you accept this.